American Journal of Kidney Diseases
Volume 46, Issue 5 , Pages 799-811, November 2005

Canadian Randomized Trial of Hemoglobin Maintenance to Prevent or Delay Left Ventricular Mass Growth in Patients With CKD

University of British Columbia, St Paul’s Hospital, Vancouver, British Columbia, Canada; and St Boniface General Hospital, Winnipeg, Manitoba, Canada.

Received 31 March 2005; accepted 1 August 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2005.08.007 on October 4, 2005.This study was investigator initiated and funded in an unrestricted manner by Ortho Biotech, Canada. O.D., of the Centre for Health Evaluation and Outcomes Sciences, University of British Columbia, performed all the analyses independently. The writing of the manuscript also was independent of the industry sponsor. A.D., B.B., S.T., and P.B. have received honoraria from Ortho Biotech; A.D. has received honoraria and served in an advisory capacity for Ortho, as well as for Amgen and Roche, which make other epoetins.

PII: S0272-6386(05)01110-8

doi:10.1053/j.ajkd.2005.08.007

Refers to article:

  • Hypothesis Versus Association: The Optimal Hemoglobin Target Debate

    Giovanni F.M. Strippoli, Jonathan C. Craig
    American Journal of Kidney Diseases November 2005 (Vol. 46, Issue 5, Pages 970-973)

American Journal of Kidney Diseases
Volume 46, Issue 5 , Pages 799-811, November 2005

Article Tools

* Image Usage & Resolution